Herrmann N - Search Results

1

Central serotonergic activity is related to the aggressive behaviors of Alzheimer's disease.

Lanctôt KL, Herrmann N, Eryavec G, van Reekum R, Reed K, Naranjo CA. Lanctôt KL, et al. Among authors: herrmann n. Neuropsychopharmacology. 2002 Oct;27(4):646-54. doi: 10.1016/s0893-133x(02)00339-1. Neuropsychopharmacology. 2002. PMID: 12377401

2

Delayed onset post-traumatic stress disorder in World War II veterans.

Herrmann N, Eryavec G. Herrmann N, et al. Can J Psychiatry. 1994 Sep;39(7):439-41. doi: 10.1177/070674379403900710. Can J Psychiatry. 1994. PMID: 7987788

3

Recent advances in geriatric psychopharmacology.

Naranjo CA, Herrmann N, Mittmann N, Bremner KE. Naranjo CA, et al. Among authors: herrmann n. Drugs Aging. 1995 Sep;7(3):184-202. doi: 10.2165/00002512-199507030-00004. Drugs Aging. 1995. PMID: 8535049 Review.

4

Pharmacotherapy of late life mood disorders.

Herrmann N, Bremner KE, Naranjo CA. Herrmann N, et al. Clin Neurosci. 1997;4(1):41-7. Clin Neurosci. 1997. PMID: 9056122 Review.

5

From transmitters to treatment: the pharmacotherapy of behavioural disturbances in dementia.

Herrmann N, Lanctôt KL. Herrmann N, et al. Can J Psychiatry. 1997 Jun;42 Suppl 1:51S-64S. Can J Psychiatry. 1997. PMID: 9220129 Review.

6

Montgomery-Asberg severity gradations.

Mittmann N, Mitter S, Borden EK, Herrmann N, Naranjo CA, Shear NH. Mittmann N, et al. Among authors: herrmann n. Am J Psychiatry. 1997 Sep;154(9):1320-1. doi: 10.1176/ajp.154.9.1320b. Am J Psychiatry. 1997. PMID: 9286204 No abstract available.

7

Paroxetine potentiates the central nervous system side effects of perphenazine: contribution of cytochrome P4502D6 inhibition in vivo.

Ozdemir V, Naranjo CA, Herrmann N, Reed K, Sellers EM, Kalow W. Ozdemir V, et al. Among authors: herrmann n. Clin Pharmacol Ther. 1997 Sep;62(3):334-47. doi: 10.1016/S0009-9236(97)90037-0. Clin Pharmacol Ther. 1997. PMID: 9333110 Clinical Trial.

8

The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline.

Ozdemir V, Naranjo CA, Herrmann N, Shulman RW, Sellers EM, Reed K, Kalow W. Ozdemir V, et al. Among authors: herrmann n. J Clin Psychopharmacol. 1998 Feb;18(1):55-61. doi: 10.1097/00004714-199802000-00009. J Clin Psychopharmacol. 1998. PMID: 9472843

9

The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis.

Mittmann N, Herrmann N, Einarson TR, Busto UE, Lanctôt KL, Liu BA, Shulman KI, Silver IL, Narango CA, Shear NH. Mittmann N, et al. Among authors: herrmann n. J Affect Disord. 1997 Dec;46(3):191-217. doi: 10.1016/s0165-0327(97)00107-9. J Affect Disord. 1997. PMID: 9547117

10

Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivo.

Ozdemir V, Naranjo CA, Shulman RW, Herrmann N, Sellers EM, Reed K, Kalow W. Ozdemir V, et al. Among authors: herrmann n. J Clin Psychopharmacol. 1998 Jun;18(3):198-207. doi: 10.1097/00004714-199806000-00004. J Clin Psychopharmacol. 1998. PMID: 9617978

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

676 results

Search Page

Filters